Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

gizmodo.com - Passant Rabie - Varda's First Pharma Deal Brings Space Drugs Closer to Reality
Varda's First Pharma Deal Brings Space Drugs Closer to Reality
Gizmodo | The Future Is Here

A California-based startup has just taken its vision of in-orbit manufacturing to the big leagues, signing a major deal with a pharmaceutical company to explore developing new, improved versions of its drugs in space. Varda Space Industries…

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
GlobeNewswire

Company announcement No. 16 / 2026 Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) Copenhagen, Denmark, May 14, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

fool.com - Jonathan Ponciano - What to Know About This Fund's $50 Million Exit From Ascendis Pharma
What to Know About This Fund's $50 Million Exit From Ascendis Pharma
The Motley Fool

On May 14, 2026, Siren disclosed in an SEC filing that it sold its entire holding of Ascendis Pharma A/S (ASND 0.22%), liquidating 235,862 shares in an estimated $52.87 million transaction based on quarterly average pricing. According to a SEC…

247wallst.com - Trey Thoelcke - Big Pharma's 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders
Big Pharma's 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders
24/7 Wall St

Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs and hunt for growth. Five therapeutic categories are absorbing most strategic capital: radiopharmaceuticals, next-gen…

thehindubusinessline.com - Alembic Pharma gets USFDA tentative approval for generic prostate cancer drug
Alembic Pharma gets USFDA tentative approval for generic prostate cancer drug
BusinessLine

Alembic Pharmaceuticals Ltd on Thursday said it has received tentative approval from the US health regulator for its generic version of Darolutamide tablets indicated for treatment of prostate cancer. The tentative approval by the U.S. Food and…

seekingalpha.com - Jonathan Block - Strong biopharma dealmaking market set to continue
Strong biopharma dealmaking market set to continue
Seeking Alpha

Experts believe the dealmaking trend will persist for several years, even into new therapeutic areas and earlier-stage assets. Experts state concerns like inflation, oil prices, and war have not slowed dealmaking, unlike past events such as the…

bmmagazine.co.uk - Amy Ingham - Hertfordshire Pharma lands £2.3m Saudi contracts after UKEF steps in to plug working capital gap
Hertfordshire Pharma lands £2.3m Saudi contracts after UKEF steps in to plug working capital gap
Business Matters

That is precisely the bind that Masters Speciality Pharma, a 41-year-old Hertfordshire specialist pharmaceutical company, found itself in last year after winning two sizeable orders from Saudi Arabia worth a combined £2.3 million. The remedy…

forbes.com - Tarek Waked - From Missions To Markets: Making Space Visible And Accessible
From Missions To Markets: Making Space Visible And Accessible
Forbes

Tarek Waked, Co-Founder & Managing Partner at Type One Ventures. I've argued that space's first true AI-style inflection will be driven by rapid orbital reusability. I still believe that. If anything, the idea is stronger now. However, what has…

rediff.com - Nandita Malik - Sensex Rallies: Telecom, Banking Shares Propel Market Recovery Amid Volatility
Sensex Rallies: Telecom, Banking Shares Propel Market Recovery Amid Volatility
Rediff.com

Indian stock markets witnessed a robust recovery, with the Sensex surging nearly 790 points, as strong buying in telecom, pharma, and private banking shares propelled the benchmark indices higher despite intraday volatility and a record-low rupee.

globenewswire.com - Orion Oyj - 105,950 Orion Corporation A shares converted into B shares
105,950 Orion Corporation A shares converted into B shares
GlobeNewswire

STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 105,950 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 105,950…

thehindubusinessline.com - Team BL - Q4 Results 15th May Live: Tata Steel, PowerGrid, Solar, SAIL, Hindustan Copper, Premier Energies, Cochin Shipyard, Godrej, Godfrey Phillips, ITC Hotels, Gland Pharma, SJVN to announce Q4 results, TMPV, HAL, JSW Steel, Apollo Tyres, VMM in focus
Q4 Results 15th May Live: Tata Steel, PowerGrid, Solar, SAIL, Hindustan Copper, Premier Energies, Cochin Shipyard, Godrej, Godfrey Phillips, ITC Hotels, Gland Pharma, SJVN to announce Q4 results, TMPV, HAL, JSW Steel, Apollo Tyres, VMM in focus
BusinessLine

Q4 Results Today, May 15, 2026 Live Updates: Find all the latest Q4 results 2026 updates of Aarti Drugs, Aether Industries, Abans Financial Services, Ashapura Intimates Fashion, AKI India, Alacrity Securities, Amber Enterprises India, Alembic…

globenewswire.com - 4basebio - 4basebio Announces Appointment of Chief Financial Officer and Board Changes
4basebio Announces Appointment of Chief Financial Officer and Board Changes
GlobeNewswire

Richard Bungay appointed as CFO, bringing a strong track record in fundraising, M&A and partnering for listed and private companies, including two major exits and over $400m raised Cambridge, UK, 14 May 2026 – 4basebio PLC (AIM: 4BB), a…

fool.com - Motley Fool Transcribing - Paysign PAYS Q1 2026 Earnings Call Transcript
Paysign PAYS Q1 2026 Earnings Call Transcript
The Motley Fool

Tuesday, May 12, 2026 at 5 p.m. ET President and Chief Executive Officer — Mark R. Newcomer Chief Financial Officer — Jeffery Baker President, Patient Affordability — Matthew Turner Chief Payments Officer — Matthew…

afr.com - Janek Drevikovsky - 'Irrational': Judge erupts as Cosette shirks Mayne's $13m legal bill
'Irrational': Judge erupts as Cosette shirks Mayne's $13m legal bill
Australian Financial Review

The courtroom stoush between jilted takeover target Mayne Pharma and its former US suitor, Cosette, has turned even uglier after a judge slammed the American medical giant for making irrational, radical, and counterintuitive arguments about why it…

adweek.com - Adweek Staff - Purpose and Practice: Transforming Health Brands for the Modern Consumer
Purpose and Practice: Transforming Health Brands for the Modern Consumer
ADWEEK

The future of brands gets decided here. Join the industry's top marketers at Brandweek for the ideas, insights, and connections shaping what's next. Get your ticket. In this episode of Adspeak by ADWEEK, chief brand and community officer Jenny…

Receive a Daily briefing on Pharma Industry News

Get Started